Ignite Creation Date:
2025-12-24 @ 5:52 PM
Ignite Modification Date:
2025-12-27 @ 7:03 AM
Study NCT ID:
NCT01137968
Status:
COMPLETED
Last Update Posted:
2016-01-26
First Post:
2010-06-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)
Sponsor:
Geron Corporation
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-small Cell Lung Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | imetelstat | View |
| None | imetelstat sodium | View |
| None | GRN163L | View |
| None | telomerase inhibitor | View |
| None | telomerase inhibition | View |
| None | maintenance therapy | View |
| None | non-small cell lung cancer | View |
| None | relapsed non-small cell lung cancer | View |
| None | advanced non-small cell lung cancer | View |
| None | NSCLC, cancer stem cells | View |
| None | Bevacizumab | View |
| None | post induction chemotherapy | View |